of NAFLD was associated with QT prolongation after adjustment for established confounders. 14 The association between QT prolongation and NAFLD among patients without diabetes has not been demonstrated. Because diabetes per se has been associated with QT prolongation, 13 it
is not clear whether the association between QT prolongation and NAFLD remains valid among patients without diabetes. Consequently, we designed this cross-sectional study to elucidate the association between NAFLD and QT prolongation among the general population with or without diabetes.
Methods Ethics Statement
This cross-sectional study was approved by the institutional review board at National Taiwan University Hospital to analyze the deidentified data. This study complied with the Declaration of Helsinki.
Patients
We recruited persons who attended health examinations at National Taiwan University Hospital, Taipei, Taiwan, between January 2005 and December 2011. Attendees of the health examinations at our center were recruited through advertised messages for health-promotion purposes, as described previously. 15 Attendees did not belong to any particular socioeconomic group or employment type. Attendees were enrolled if they attended the examination for the first time and did not meet exclusion criteria. Participants were categorized into 4 groups according to the severity of NAFLD on abdominal ultrasonography: (1) no NAFLD (the reference group), (2) mild NAFLD, (3) moderate NAFLD, and (4) severe NAFLD. Grading for the severity of NAFLD is described in detail under "Abdominal Ultrasonography" in the Methods section.
Exclusion Criteria
Persons with the following conditions were excluded from our study: (1) aged <20 years; (2) estimated alcohol consumption >20 g/day for men and >10 g/day for women; (3) history of viral hepatitis or seropositivity for hepatitis B virus surface antigen or anti-hepatitis C antibody; (4) history of liver cirrhosis; (5) incomplete results of abdominal ultrasonography; (6) 12-lead ECG findings including atrial fibrillation, atrial flutter, complete left or right bundle-branch block, or pacemaker rhythm; and (7) taking antiarrhythmic medications.
Protocol of the Health Examinations
On the day of the health examination, a standard questionnaire was administered by a trained nurse to obtain data on the demographic characteristics, medical history, and health habits of the participants. Cigarette smoking was categorized into current smokers and nonsmokers. Significant alcohol consumption was defined as alcohol intake >20 g/day for men and >10 g/day for women. Blood pressures were measured at 8 to 9 AM before taking any medication. Systolic and diastolic blood pressures were measured in both arms in the sitting position using a mercury sphygmomanometer, with the arm supported at heart level after the subject sat quietly for 10 minutes. The higher reading for the 2 arms was used in the analysis.
Anthropometric Measurements
Body height was measured to the nearest 0.1 cm. Body weight was measured with an electronic scale to the nearest 0.1 kg with participants wearing a hospital gown. Waist circumferences were measured according to the method of the World Health Organization and the International Diabetes Federation to the nearest 0.1 cm. 16 Body mass index was calculated based on the body weight in kilograms divided by the square of the body height in meters.
Blood Chemistry
All participants received blood biochemistry tests after an overnight 12-hour fast. Blood glucose concentration was measured by the hexokinase method (Roche Diagnostic GmbH). Plasma hemoglobin A1c was measured using an automatic analyzer (HLC-723 G7 HPLC system; Tosoh Corporation). The hemoglobin A1c assay was certified by the National Glycohemoglobin Standardization Program 17 and standardized to the Diabetes Control and Complications Trial reference assay. Hepatitis B surface antigen and hepatitis C virus antibody were measured by the AxSYM system (Abbott Laboratories). The laboratory is qualified by an external quality-assurance program of the Taiwan Society of Laboratory Medicine twice a year.
Definitions
Hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or a reported history of hypertension. Central obesity was defined as waist circumference ≥90 cm in men and ≥80 cm in women. Metabolic syndrome was diagnosed using the criteria defined in the Adult Treatment Panel III, with a modification of waist circumference, as appropriate for Asian participants. 
ECG and QT Interval
A 12-lead ECG was recorded by a trained nurse for 10 seconds with the participant in the supine position on the morning of the same day as the health examination. ECGs were performed using a MAC 3500 resting ECG machine (GE Healthcare). ECGs were analyzed with computerized automated analysis software imbedded in the ECG machine and then were confirmed by a physician. The QT interval was defined as being from the first deflection from the isoelectric line of the QRS complex to the end of the T wave. The corrected QT (QTc) interval was derived from Bazett's formula (QTc equals the QT interval divided by the square root of the RR interval) to correct the QT interval for heart rate. 20 A linear QT correction formula proposed by Hodges et al (QTc Hodges=QT interval+1059[1/RR intervalÀ1]) was also used as an alternative method of QT correction. QTc by Hodges' formula was used as the dependent variable in the multivariable logistic regression analysis after adjustment, as a sensitivity analysis. 21 Resting heart rates were obtained from ECG readings. The diagnosis of left ventricular hypertrophy on ECG was based on Sokolow's voltage criteria. Complete left bundle-branch block was defined as a QRS duration of ≥120 ms with wide S wave or rS in V1 and wide terminal R wave in I, aVL, and V5 to V6, without the presence of a Q wave in the same lead. Complete left bundle-branch block was defined as a QRS duration ≥120 ms with wide terminal R in V1 and wide terminal S in I, aVL, and V5 to V6. The diagnosis of atrial fibrillation was defined as an irregular rhythm occurring irregularly with a range of RR intervals >15% of average RR intervals and RR intervals not organized. Atrial flutter was diagnosed if an atrial rate of 200 to 350 beats per minute was detected.
Abdominal Ultrasonography
Abdominal ultrasonography was performed on the same day as the health examination by experienced gastrointestinal specialists with high-resolution ultrasonography (Aplio XG SSA-790A; Toshiba) using a 3.5-MHz linear transducer. The ultrasound diagnostic criterion for NAFLD was increased parenchymal brightness compared with the right renal cortex. The level of brightness was graded as mild, moderate, or severe, according to the criteria described by Needleman et al. 22 Briefly were performed to examine the relationship between the presence of QTc prolongation and the severity of NAFLD in men or women. In these analyses, we set the group without NAFLD as the reference group to determine the existence of a dose-dependent relationship. Subgroup analyses were performed among different age groups (by tertiles), status of diabetes (with or without), status of hypertension (with or without), status of metabolic syndrome (with or without), status of left ventricular hypertrophy (with or without), and body mass index groups (by tertiles). Sensitivity analyses were performed using 3 different cutoff points for QTc prolongation and 2 different definitions for alcohol consumption to exclude participants with alcoholic fatty liver disease. The 3 alternative cutoffs for QTc prolongation were (1) QTc ≥440 ms (men) or ≥450 ms (women), (2) QTc ≥440 ms (men) or ≥460 ms (women), and (3) QTc ≥470 ms. The 2 alternative definitions for alcohol consumption were (1) estimated alcohol consumption <10 g per week and (2) no alcohol consumption. Sensitivity analysis using an alternative QT correction formula, Hodges' formula, for multivariable logistic regression with full adjustment was also performed among all participants. The same set of predictors was adjusted in the sensitivity analyses.
A 2-tailed P value <0.05 was considered to demonstrate statistical significance for all analyses. Listwise deletion was used to account for missing data. Statistical analyses were performed using the Stata version 11.0 software package (StataCorp LP).
Results
A total of 31 116 patients were enrolled in this study. The mean age was 50.1 years (SD 12.1 years), and men represented 16 014 (51.5%) of the participants. The mean QTc interval of all participants was 421.3 ms (SD 45.4 ms). A total of 9781 participants (31.4%) had a QTc interval of >440 ms. The baseline characteristics of the participants stratified by the severity of NAFLD are shown in Table 1 . An increase in the severity of NAFLD was associated with an increase in the severity of anthropometric and metabolic parameters, including body mass index, blood pressure, cholesterol, triglycerides, and glycemic parameters. The QT and QTc intervals increased progressively with increased severity of NAFLD ( Figure) . The QTc derived from Hodges' formula was shorter than QTc derived from Bazett's formula ( Table 1 ). The QTc intervals derived from these 2 formulas were highly correlated in our participants (correlation coefficient 0.980, P<0.05). (Table 2) . Table 3 shows the odds ratios for the severity of NAFLD to predict the presence of QTc prolongation >440 ms. In the fully adjusted model, the severity of NAFLD was significantly associated with a higher risk for QTc prolongation according to the following odds ratios. For mild, moderate, and severe NAFLD in women, odds ratios were 1.11 (95% CI 1.01 to 1.21, P<0.05), 1.61 (95% CI 1.36 to 1.90, P<0.001), and 1.31 (95% CI 1.16 to 2.24, P<0.01), respectively, compared with no NAFLD. In men, odds ratios were 1.11 (95% CI 1.01 to 1.21, P<0.05), 1.39 (95% CI 1.22 to 1.59, P<0.001), and 1.87 (95% CI 1.51 to 2.31, P<0.001) for mild, moderate, and severe NAFLD, respectively, compared with no NAFLD. There was no significant interaction between NAFLD severity and diabetes in the model. The results were similar when analyzed by Hodges' criteria, although the odds ratio for mild NAFLD did not reached statistical significance (Table 3) . We performed sensitivity analyses using different criteria for QTc prolongation: (1) QTc ≥440 ms in men or ≥450 ms in women; (2) QTc ≥440 ms in men or ≥460 ms in women; (3) QTc ≥470 ms and alcohol consumption, with estimated alcohol consumption of either <10 g per week or none (nondrinker). In these sensitivity analyses, the severity of NAFLD remained significantly associated with a higher risk of QTc prolongation after changing the criteria for QTc prolongation and the criteria for alcoholic consumption in the majority of the subgroups (Tables 4 through 6 ). Moderate and severe NAFLD were consistently associated with higher risk of QTc prolongation using the criteria for QTc interval ≥440 ms in men and ≥450 ms in women or ≥440 ms in men and ≥460 ms in women. The association between NAFLD and QTc prolongation using the criteria for QTc intervals ≥470 ms was attenuated, especially among those participants who never drank (Tables 4 through 6 ).
Discussion
The main finding of this study was that NAFLD was associated with a prolonged QTc interval and a higher risk of prolonged QTc interval in the general population that was independent of The mechanism underlying the association between NA-FLD and QTc prolongation is not totally clear. Traditional cardiometabolic risk factors have been associated with the QTc interval. The prevalence of diabetes, hypertension, and smoking has been found to increase progressively as the QT interval increases in a large population-based cohort study. 10 Lower levels of high-density lipoprotein cholesterol were also shown to be positively associated with QT prolongation. 23 In a pilot study, reconstituted high-density lipoprotein was shown to shorten the QT interval in cardiomyocytes and in dyslipidemic patients and healthy volunteers. 24 In our study, we observed a significant association of blood pressure, hemoglobin A1c, and high-density lipoprotein concentration with QTc interval. The association between the severity of NAFLD and QTc interval remained significant after rigorous adjustment for these factors.
Another potential mechanism that contributes to the association between NAFLD and the QTc interval is inflammation. The inflammatory marker C-reactive protein has been associated with the QTc interval in prior studies. 25, 26 In a recent study among 1716 elderly participants, high-sensitivity C-reactive protein was associated with QTc prolongation in men, whereas soluble tumor necrosis factor receptor 1 was associated with QTc prolongation in women. 27 In vitro studies have shown that TNF-a induces calcium leakage from the sarcoplasmic reticulum, causing action potential prolongation and arrhythmias. 28, 29 In our study, we also observed an association between high-sensitivity C-reactive protein and the QTc interval. The association between the presence and the severity of NAFLD and QT interval remained significant after adjustment for high-sensitivity C-reactive protein.
A third potential mechanism that contributes to the association between NAFLD and the QT interval is reflected by the overactivated sympathetic nervous system that occurs in NAFLD. The sympathetic nervous system has long been associated with QTc prolongation. 30 In our prior study among 497 participants with and without NAFLD, the presence of NAFLD was associated with higher sympathetic activity, as assessed by heart rate variability analysis. This association was independent of leptin or subclinical inflammation. 31 We did not measure the sympathetic activity in this current study. Further investigation is warranted to determine whether sympathetic overactivity contributes to QTc prolongation among patients with NAFLD.
Clinical Implications
In the general population, QTc prolongation has been associated with adverse outcomes in many but not all epidemiology studies. The early Framingham Heart Study did Continued not reveal an association between QTc interval with all-cause mortality or sudden death. 32 The later studies, including the Cardiovascular Health Study, the Strong Heart study, the Rotterdam study, the NHAMES study, and a recent metaanalysis, have all supported the association between QT prolongation and increased cardiovascular mortality and sudden cardiac death in the general population. [9] [10] [11] [12] QT prolongation among patients with diabetes has also been associated with all-cause and cardiovascular mortality. 33, 34 QT prolongation among those with hepatic disease has mostly been investigated among patients with liver cirrhosis. QT prolongation is common in patients with liver cirrhosis and is associated with a lower survival rate. 35 The QTc interval is normalized after liver transplantation among half of the patients with liver cirrhosis and QT prolongation. 36 The association between the QTc interval and NAFLD has been found in patients with diabetes, 14 but it has not yet been demonstrated in the general population. The independent value of this association to predict cardiovascular outcomes among patients with NAFLD has not yet been validated. Given the fact that NAFLD has an increased risk for cardiovascular morbidity and mortality, 6 a search for every possible link between NAFLD and cardiovascular disease is key to improving outcomes among these patients. Our findings suggest that NAFLD-associated QT prolongation might be a link to adverse cardiovascular outcomes among these patients. Further confirmation using a large cohort study to assess whether QTc prolongation among patients with NAFLD independently contributes to future cardiovascular events or all-cause mortality is warranted. The strengths of this study include the large sample size and a standardized protocol from a health management program to collect blood samples and perform ECG recordings. Moreover, sensitivity analyses using different formulas for QTc interval and different criteria for QTc prolongation and alcohol consumption minimized bias from misclassification. Finally, the independent association after adjustment of various cardiometabolic risk factors, including metabolic syndrome, clearly demonstrated the contribution of NAFLD to QTc prolongation.
Limitations
Our study has several limitations. First, the design of this study was cross-sectional and thus could not validate the causal relationship between NAFLD and QT intervals. Future interventional studies with exercise or weight loss to downgrade the severity of NAFLD may help elucidate the temporal relationship between NAFLD and QTc. Second, the diagnosis of NAFLD was assessed by abdominal ultrasound, which has sensitivity of 85% to 90% and specificity of 70% to 80% to detect liver fat >10%. The sensitivity and specificity are lower Table 3 . for detecting liver fat <10%. 37 Consequently, our study might have underestimated the prevalence of NAFLD. Third, some factors including adipocytokines, fasting insulin, homeostatic model assessment-insulin resistance, sympathetic activity, unreported medication use, and genetic factors were not measured in this study. The possible confounding effects of these factors cannot be excluded. Finally, our results could not explain the underlying mechanism of the association between NAFLD and QT prolongation. Further studies are needed to clarify the mechanism.
Conclusion
The severity of NAFLD was associated with prolonged QTc intervals and higher risk for QTc prolongation in the general population with or without diabetes.
